Outsourcing in Clinical Trials DACH 2022
Holiday In, Munich City Centre, Munich, GermanyAttending the Outsourcing in Clinical Trials DACH 2022? Clinical ink will be in attendance, come find us at booth #4. This event will focus on […]
12 events found.
SCOPE Summit 2023 (Orlando, Florida + Virtual)
Rosen Shingle Creek 9939 Universal Blvd, Orlando, FL, United StatesOver four stimulating days of in-depth discussions in 28 different conferences, 3 plenary keynote sessions, the 7th annual Participant Engagement Awards, special cross-department panels, the […]
Outsourcing In Clinical Trials West Coast 2023
Hyatt Regency San Francisco Airport 1333 Old Bayshore Hwy, Burlingame, CA, United StatesFor the 15th Annual event, the flagship OCT show will focus on providing delegates with practical take-aways and solutions to their most current operational and […]
SXSW LIVE PODCAST PANEL – Innovative Data Approaches to Clinical Trial Recruitment
How can you access larger pools of clinical trial participants? Gain the ability to target specific populations? Address potential ethical considerations? Ensure timely data accuracy? […]
Webinar – The Future of Data Platforms For Digital Biomarkers: Accelerating Parkinson’s Disease and Movement Disorders Research
Webinar - The Future of Data Platforms For Digital Biomarkers: Accelerating Parkinson’s Disease and Movement Disorders Research Parkinson's Disease and Movement Disorder research is accelerating […]
Solving Data Collection Challenges in Lupus Trials with the Electronic Lupus Assessment Suite
11am EDT (NA) / 4pm BST (UK) / 5pm CEST (EU-Central) Systemic Lupus Erythematosus (SLE) clinical trials are complex and can be challenging to conduct. […]
How Patient-Centered Technologies Can Elevate Diabetes Clinical Trials to Align with Current Standards of Care
For years, diabetes clinical trials have been trailing clinical care because of regulatory and logistical challenges with utilizing CGMs in a clinical trial setting. But, because of recent FDA clearance of commercially available devices, these CGM devices have started to be implemented more widely in the clinical trial setting – at least in the United States – but global trials still present challenges.
Predicting ALS Progression in Remote Sensor-Based Assessments
Don't miss Clinical ink Principal Scientist David Anderson on "Predicting ALS Progression in Remote Sensor-Based Assessments" at the International Congress of Parkinson’s Disease and Movement […]
New Approaches to Adherence and Prevention of Dropouts: The Digital Era of Patient Engagement
In this informative webinar, discover strategies for patient engagement and digital therapeutics relating to the management of social determinants of health in cardiometabolic diseases and recent Food and Drug Administration (FDA) guidance on the future of Lupus research.
GlucoseReady™: A Digital Platform for Assessing Behavior, Glucose, Symptoms, and Biometrics in Cardiometabolic Disease.
Come hear David Anderson, PhD speak at SCOPE on Tuesday February 13th at 5:30pm. David will be presenting Clinical ink’s latest offering, GlucoseReady™: A Digital […]
A feasibility study of smartphone sensors to assess the effect of acute high altitude (3,800m) exposure on cognition and motor function in healthy participants.
We are excited to announce that David Anderson will be presenting at #DIAEurope March 12-14, 2024 on “A feasibility study of smartphone sensors to assess the effect of acute high altitude […]
Webinar – Electronic Data Capture Redefined: Challenging the Norm with eSource Innovation
In this informative webinar, discover strategies for patient engagement and digital therapeutics relating to the management of social determinants of health in cardiometabolic diseases and recent Food and Drug Administration (FDA) guidance on the future of Lupus research.
